N. Abdel-Samad

A Prospective Economic Analysis of Early Outcome Data From the Alliance A041202/ CCTG CLC.2 Randomized Phase III Trial Of Bendamustine-Rituximab Compared With Ibrutinib-Based Regimens in Untreated Older Patients With Chronic Lymphocytic Leukemia.

Bingshu E. Chen, Allison M. Booth, S. Mandrekar, 2021, Clinical lymphoma, myeloma & leukemia.

A Case of Acquired Angioedema with Low C1 Inhibitor (C1-INH) Associated with Splenic Marginal Zone Lymphoma

N. Abdel-Samad, Judit Kókai, 2019, The American journal of case reports.

CANADIAN CANCER TRIALS GROUP (CCTG) LY.17: A RANDOMIZED PHASE II STUDY EVALUATING NOVEL SALVAGE THERAPY PRE‐AUTOLOGOUS STEM CELL TRANSPLANT (ASCT) IN RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA (RR‐DLBCL) ‐ OUTCOME OF IBRUTINIB + R‐GDP

A. Prica, J. Kuruvilla, L. Shepherd, 2017 .

Treatment with Recombinant Factor XIII (Tretten) in a Pregnant Woman with Factor XIII Deficiency

N. Abdel-Samad, 2017, The American journal of case reports.

Severe gastrointestinal hemorrhage during targeted therapy for advanced breast carcinoma.

H. Assi, N. Abdel-Samad, 2014, Current oncology.